<s id="wsj_0533.1"> 16
2 	 0 	 N/N 	 1 	 bidders Two
2 	 1 	 N/N 	 1 	 bidders rival
2 	 3 	 (NP\NP)/NP 	 1 	 bidders for
2 	 6 	 (S[dcl]\NP)/NP 	 1 	 bidders extended
5 	 3 	 (NP\NP)/NP 	 2 	 BioSciences for
5 	 4 	 N/N 	 1 	 BioSciences Connaught
6 	 15 	 (S\NP)\(S\NP) 	 2 	 extended Friday
8 	 6 	 (S[dcl]\NP)/NP 	 2 	 offers extended
8 	 7 	 NP[nb]/N 	 1 	 offers their
8 	 10 	 (S[b]\NP)/NP 	 1 	 offers acquire <XB>
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 acquire to
14 	 10 	 (S[b]\NP)/NP 	 2 	 manufacturer acquire
14 	 11 	 NP[nb]/N 	 1 	 manufacturer the
14 	 12 	 N/N 	 1 	 manufacturer Toronto-based
14 	 13 	 N/N 	 1 	 manufacturer vaccine
<\s>
<s id="wsj_0533.2"> 40
2 	 0 	 N/N 	 1 	 S.A. Institut
2 	 1 	 N/N 	 1 	 S.A. Merieux
2 	 4 	 (NP\NP)/(S[dcl]\NP) 	 1 	 S.A. which
2 	 5 	 ((S[dcl]\NP)/PP)/NP 	 1 	 S.A. offered <XB>
2 	 24 	 (S[dcl]\NP)/S[dcl] 	 1 	 S.A. said
5 	 4 	 (NP\NP)/(S[dcl]\NP) 	 2 	 offered which
7 	 6 	 (N/N)/(N/N) 	 2 	 million 942
9 	 5 	 ((S[dcl]\NP)/PP)/NP 	 3 	 dollars offered
9 	 7 	 N/N 	 1 	 dollars million
9 	 8 	 N/N 	 1 	 dollars Canadian
9 	 10 	 (NP\NP)/NP 	 1 	 dollars -LRB-
11 	 10 	 (NP\NP)/NP 	 2 	 US$ -LRB-
13 	 11 	 N/N[num] 	 1 	 million US$
13 	 12 	 N/N 	 1 	 million 801.2
17 	 5 	 ((S[dcl]\NP)/PP)/NP 	 3 	 C$ offered
17 	 19 	 (NP\NP)/N 	 1 	 C$ a
18 	 17 	 N/N[num] 	 1 	 37 C$
20 	 19 	 (NP\NP)/N 	 2 	 share a
21 	 5 	 ((S[dcl]\NP)/PP)/NP 	 2 	 for offered
22 	 21 	 PP/NP 	 1 	 Connaught for
25 	 26 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it would
25 	 27 	 ((S[b]\NP)/PP)/NP 	 1 	 it extend <XB>
26 	 24 	 (S[dcl]\NP)/S[dcl] 	 2 	 would said
27 	 26 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 extend would
29 	 27 	 ((S[b]\NP)/PP)/NP 	 3 	 bid extend
29 	 28 	 NP[nb]/N 	 1 	 bid its
29 	 31 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 bid due <XB>
32 	 31 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to due
33 	 32 	 (S[to]\NP)/(S[b]\NP) 	 2 	 expire to
33 	 35 	 (S\NP)\(S\NP) 	 2 	 expire Thursday
35 	 34 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 Thursday last
37 	 27 	 ((S[b]\NP)/PP)/NP 	 2 	 to extend
38 	 37 	 PP/NP 	 1 	 Nov. to
39 	 38 	 N/N[num] 	 1 	 6 Nov.
<\s>
<s id="wsj_0533.3"> 31
2 	 1 	 (N/N)/N[num] 	 2 	 30-a-share C$
3 	 0 	 NP[nb]/N 	 1 	 bid A
3 	 1 	 (N/N)/N[num] 	 1 	 bid C$
3 	 4 	 (NP\NP)/NP 	 1 	 bid by
3 	 26 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 bid was
3 	 27 	 (S[pss]\NP)/PP 	 1 	 bid extended <XB>
6 	 4 	 (NP\NP)/NP 	 2 	 Ltd. by
6 	 5 	 N/N 	 1 	 Ltd. Ciba-Geigy
10 	 4 	 (NP\NP)/NP 	 2 	 company by
10 	 8 	 NP[nb]/N 	 1 	 company a
10 	 9 	 N/N 	 1 	 company pharmaceutical
10 	 11 	 S[pss]\NP 	 1 	 company based <XB>
11 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
13 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 Basel in
15 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 Switzerland in
20 	 4 	 (NP\NP)/NP 	 2 	 Corp. by
20 	 18 	 N/N 	 1 	 Corp. California-based
20 	 19 	 N/N 	 1 	 Corp. Chiron
24 	 4 	 (NP\NP)/NP 	 2 	 concern by
24 	 22 	 NP[nb]/N 	 1 	 concern a
24 	 23 	 N/N 	 1 	 concern bioresearch
27 	 26 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 extended was
28 	 27 	 (S[pss]\NP)/PP 	 2 	 to extended
29 	 28 	 PP/NP 	 1 	 Nov. to
30 	 29 	 N/N[num] 	 1 	 16 Nov.
<\s>
<s id="wsj_0533.4"> 8
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 It had
0 	 3 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 It due <XB>
2 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been had
3 	 2 	 (S[pt]\NP)/(S[adj]\NP) 	 2 	 due been
4 	 3 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to due
5 	 4 	 (S[to]\NP)/(S[b]\NP) 	 2 	 expire to
5 	 7 	 (S\NP)\(S\NP) 	 2 	 expire evening
7 	 6 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 evening Friday
<\s>
<s id="wsj_0533.5"> 23
0 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Merieux said
2 	 1 	 (S\NP)/(S\NP) 	 2 	 said previously
3 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it would
3 	 5 	 (S[b]\NP)/S[dcl] 	 1 	 it ensure <XB>
4 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 would said
5 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 ensure would
7 	 6 	 NP[nb]/N 	 1 	 bid its
7 	 8 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 bid remained
7 	 9 	 S[adj]\NP 	 1 	 bid open <XB>
8 	 5 	 (S[b]\NP)/S[dcl] 	 2 	 remained ensure
8 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 remained pending
9 	 8 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 open remained
13 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 decision pending
13 	 11 	 NP[nb]/N 	 1 	 decision a
13 	 12 	 N/N 	 1 	 decision final
13 	 14 	 (NP\NP)/NP 	 1 	 decision by
13 	 17 	 (NP\NP)/S[qem] 	 1 	 decision on
16 	 14 	 (NP\NP)/NP 	 2 	 regulators by
16 	 15 	 N/N 	 1 	 regulators Canadian
18 	 17 	 (NP\NP)/S[qem] 	 2 	 whether on
19 	 18 	 S[qem]/(S[to]\NP) 	 1 	 to whether
20 	 19 	 (S[to]\NP)/(S[b]\NP) 	 2 	 approve to
22 	 20 	 (S[b]\NP)/NP 	 2 	 takeover approve
22 	 21 	 NP[nb]/N 	 1 	 takeover the
<\s>
<s id="wsj_0533.6"> 22
0 	 13 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Merieux is
0 	 14 	 S[pss]\NP 	 1 	 Merieux controlled <XB>
3 	 2 	 NP[nb]/N 	 1 	 vaccine a
3 	 7 	 S[pss]\NP 	 1 	 vaccine based <XB>
3 	 13 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 vaccine is
3 	 14 	 S[pss]\NP 	 1 	 vaccine controlled <XB>
6 	 2 	 NP[nb]/N 	 1 	 firm a
6 	 5 	 N/N 	 1 	 firm bioresearch
6 	 7 	 S[pss]\NP 	 1 	 firm based <XB>
6 	 13 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 firm is
6 	 14 	 S[pss]\NP 	 1 	 firm controlled <XB>
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
9 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 Lyon in
11 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 France in
14 	 13 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 controlled is
14 	 16 	 (S\NP)\(S\NP) 	 2 	 controlled %
14 	 17 	 ((S\NP)\(S\NP))/NP 	 2 	 controlled by
16 	 15 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 50.1
21 	 17 	 ((S\NP)\(S\NP))/NP 	 3 	 S.A by
21 	 18 	 N/N 	 1 	 S.A state-owned
21 	 19 	 N/N 	 1 	 S.A Rhone
21 	 20 	 N/N 	 1 	 S.A Poulenc
<\s>
<s id="wsj_0533.7"> 30
2 	 0 	 NP[nb]/N 	 1 	 government The
2 	 1 	 N/N 	 1 	 government Canadian
2 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 government said
4 	 3 	 (S\NP)/(S\NP) 	 2 	 said previously
5 	 6 	 (NP[nb]/N)\NP 	 2 	 Merieux 's
7 	 6 	 (NP[nb]/N)\NP 	 1 	 bid 's
7 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 bid did
7 	 10 	 ((S[b]\NP)/PP)/NP 	 1 	 bid offer <XB>
7 	 18 	 S[pss]\NP 	 1 	 bid approved <XB>
7 	 21 	 ((S[b]\NP)/NP)/NP 	 1 	 bid gave <XU>
7 	 27 	 (S[b]\NP)/NP 	 1 	 bid submit <XU>
8 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 did said
8 	 9 	 (S\NP)\(S\NP) 	 2 	 did n't
10 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 offer did
13 	 10 	 ((S[b]\NP)/PP)/NP 	 3 	 benefit offer
13 	 11 	 N/N 	 1 	 benefit enough
13 	 12 	 N/N 	 1 	 benefit net
14 	 10 	 ((S[b]\NP)/PP)/NP 	 2 	 to offer
15 	 14 	 PP/NP 	 1 	 Canada to
17 	 16 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
18 	 17 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 approved be
21 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 gave did
22 	 21 	 ((S[b]\NP)/NP)/NP 	 3 	 Merieux gave
25 	 21 	 ((S[b]\NP)/NP)/NP 	 2 	 mid-November gave
25 	 23 	 NP[nb]/N 	 1 	 mid-November an
25 	 24 	 N/N 	 1 	 mid-November until
27 	 26 	 (S[to]\NP)/(S[b]\NP) 	 2 	 submit to
29 	 27 	 (S[b]\NP)/NP 	 2 	 information submit
29 	 28 	 N/N 	 1 	 information additional
<\s>
<s id="wsj_0533.8"> 26
1 	 0 	 N/N 	 1 	 officials Merieux
1 	 2 	 (S[dcl]\NP)/S[em] 	 1 	 officials said
2 	 4 	 (S\NP)\(S\NP) 	 2 	 said week
4 	 3 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 week last
5 	 2 	 (S[dcl]\NP)/S[em] 	 2 	 that said
6 	 7 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 they are
6 	 9 	 (S[adj]\NP)/S[dcl] 	 1 	 they confident <XB>
7 	 5 	 S[em]/S[dcl] 	 1 	 are that
9 	 7 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 confident are
9 	 8 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 confident highly
11 	 10 	 NP[nb]/N 	 1 	 offer the
11 	 12 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 offer will
11 	 14 	 S[pss]\NP 	 1 	 offer approved <XB>
12 	 9 	 (S[adj]\NP)/S[dcl] 	 2 	 will confident
13 	 12 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
14 	 13 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 approved be
14 	 15 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 approved once
16 	 17 	 ((S[dcl]\NP)/PP)/NP 	 1 	 it submits
17 	 15 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 submits once
18 	 17 	 ((S[dcl]\NP)/PP)/NP 	 3 	 details submits
18 	 19 	 (NP\NP)/NP 	 1 	 details of
22 	 19 	 (NP\NP)/NP 	 2 	 investments of
22 	 20 	 NP[nb]/N 	 1 	 investments its
22 	 21 	 N/N 	 1 	 investments proposed
23 	 17 	 ((S[dcl]\NP)/PP)/NP 	 2 	 to submits
25 	 23 	 PP/NP 	 1 	 regulators to
25 	 24 	 N/N 	 1 	 regulators federal
<\s>
<s id="wsj_0533.9"> 23
1 	 0 	 NP[nb]/N 	 1 	 offers Both
1 	 2 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 offers are
1 	 3 	 (S[adj]\NP)/PP 	 1 	 offers conditional <XB>
3 	 2 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 conditional are
4 	 3 	 (S[adj]\NP)/PP 	 2 	 on conditional
6 	 4 	 PP/NP 	 1 	 approvals on
6 	 5 	 N/N 	 1 	 approvals regulatory
9 	 8 	 N/N 	 1 	 shares enough
9 	 10 	 (S[ng]\NP)/(S[pss]\NP) 	 1 	 shares being
9 	 11 	 S[pss]\NP 	 1 	 shares tendered <XB>
9 	 13 	 ((S[b]\NP)/NP)/NP 	 1 	 shares give <XB>
10 	 4 	 PP/NP 	 1 	 being on
11 	 10 	 (S[ng]\NP)/(S[pss]\NP) 	 2 	 tendered being
13 	 12 	 (S[to]\NP)/(S[b]\NP) 	 2 	 give to
15 	 13 	 ((S[b]\NP)/NP)/NP 	 3 	 bidders give
15 	 14 	 NP[nb]/N 	 1 	 bidders the
17 	 13 	 ((S[b]\NP)/NP)/NP 	 2 	 majority give
17 	 16 	 NP[nb]/N 	 1 	 majority a
17 	 18 	 (NP\NP)/NP 	 1 	 majority of
19 	 20 	 (NP[nb]/N)\NP 	 2 	 Connaught 's
21 	 18 	 (NP\NP)/NP 	 2 	 shares of
21 	 20 	 (NP[nb]/N)\NP 	 1 	 shares 's
21 	 22 	 S[adj]\NP 	 1 	 shares outstanding <XB>
<\s>
<s id="wsj_0533.10"> 47
1 	 0 	 N/N 	 1 	 Merieux Institut
1 	 3 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Merieux which
1 	 5 	 (S[dcl]\NP)/NP 	 1 	 Merieux holds <XB>
1 	 13 	 (S[dcl]\NP)/S[em] 	 1 	 Merieux said
5 	 3 	 (NP\NP)/(S[dcl]\NP) 	 2 	 holds which
5 	 4 	 (S\NP)/(S\NP) 	 2 	 holds already
8 	 7 	 (N/N)/(N/N) 	 2 	 % 12.5
9 	 5 	 (S[dcl]\NP)/NP 	 2 	 stake holds
9 	 6 	 NP[nb]/N 	 1 	 stake a
9 	 8 	 N/N 	 1 	 stake %
9 	 10 	 (NP\NP)/NP 	 1 	 stake in
11 	 10 	 (NP\NP)/NP 	 2 	 Connaught in
14 	 13 	 (S[dcl]\NP)/S[em] 	 2 	 that said
17 	 15 	 (S/S)/NP 	 2 	 close at
17 	 16 	 NP[nb]/N 	 1 	 close the
17 	 18 	 (NP\NP)/NP 	 1 	 close of
19 	 18 	 (NP\NP)/NP 	 2 	 business of
23 	 22 	 N/N 	 1 	 shares 5,745,188
23 	 24 	 (NP\NP)/NP 	 1 	 shares of
23 	 41 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 shares had
23 	 43 	 (S[pss]\NP)/PP 	 1 	 shares tendered <XB>
25 	 24 	 (NP\NP)/NP 	 2 	 Connaught of
29 	 27 	 (N/N)/N[num] 	 2 	 million C$
29 	 28 	 N/N 	 1 	 million 44.3
31 	 27 	 (N/N)/N[num] 	 1 	 amount C$
31 	 30 	 N/N 	 1 	 amount face
31 	 32 	 (NP\NP)/NP 	 1 	 amount of
31 	 35 	 S[adj]\NP 	 1 	 amount convertible <XB>
31 	 41 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 amount had
31 	 43 	 (S[pss]\NP)/PP 	 1 	 amount tendered <XB>
33 	 32 	 (NP\NP)/NP 	 2 	 debentures of
35 	 36 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 convertible into
39 	 36 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 shares into
39 	 37 	 N/N 	 1 	 shares 1,826,596
39 	 38 	 N/N 	 1 	 shares common
41 	 14 	 S[em]/S[dcl] 	 1 	 had that
41 	 15 	 (S/S)/NP 	 1 	 had at
41 	 20 	 S/S 	 1 	 had Thursday
42 	 41 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been had
43 	 42 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 tendered been
44 	 43 	 (S[pss]\NP)/PP 	 2 	 to tendered
46 	 44 	 PP/NP 	 1 	 offer to
46 	 45 	 NP[nb]/N 	 1 	 offer its
<\s>
<s id="wsj_0533.11"> 20
2 	 0 	 (S/S)/NP 	 2 	 close At
2 	 1 	 NP[nb]/N 	 1 	 close the
2 	 3 	 (NP\NP)/NP 	 1 	 close of
4 	 3 	 (NP\NP)/NP 	 2 	 business of
7 	 10 	 (S[dcl]\NP)/S[dcl] 	 1 	 Ciba-Geigy said
9 	 10 	 (S[dcl]\NP)/S[dcl] 	 1 	 Chiron said
10 	 0 	 (S/S)/NP 	 1 	 said At
10 	 5 	 S/S 	 1 	 said Thursday
13 	 11 	 N/N 	 1 	 shares 11,580
13 	 12 	 N/N 	 1 	 shares common
13 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 shares had
13 	 16 	 (S[pss]\NP)/PP 	 1 	 shares tendered <XB>
14 	 10 	 (S[dcl]\NP)/S[dcl] 	 2 	 had said
15 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been had
16 	 15 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 tendered been
17 	 16 	 (S[pss]\NP)/PP 	 2 	 to tendered
19 	 17 	 PP/NP 	 1 	 offer to
19 	 18 	 NP[nb]/N 	 1 	 offer their
<\s>
<s id="wsj_0533.12"> 10
2 	 0 	 (S/S)/NP 	 2 	 report At
2 	 1 	 N/N 	 1 	 report last
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 Connaught had
5 	 0 	 (S/S)/NP 	 1 	 had At
7 	 6 	 (N/N)/(N/N) 	 2 	 million 21.8
8 	 5 	 (S[dcl]\NP)/NP 	 2 	 shares had
8 	 7 	 N/N 	 1 	 shares million
8 	 9 	 S[adj]\NP 	 1 	 shares outstanding <XB>
<\s>
<s id="wsj_0533.13"> 30
5 	 2 	 NP[nb]/N 	 1 	 Court the
5 	 3 	 N/N 	 1 	 Court Ontario
5 	 4 	 N/N 	 1 	 Court Supreme
5 	 6 	 (S[dcl]\NP)/S[dcl] 	 1 	 Court said
6 	 0 	 S/S 	 1 	 said Separately
7 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it will
7 	 9 	 (S[b]\NP)/NP 	 1 	 it postpone <XB>
8 	 6 	 (S[dcl]\NP)/S[dcl] 	 2 	 will said
9 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 postpone will
9 	 10 	 (S\NP)\(S\NP) 	 2 	 postpone indefinitely
12 	 9 	 (S[b]\NP)/NP 	 2 	 ruling postpone
12 	 11 	 NP[nb]/N 	 1 	 ruling a
12 	 13 	 (NP\NP)/NP 	 1 	 ruling on
15 	 13 	 (NP\NP)/NP 	 2 	 lawsuit on
15 	 14 	 NP[nb]/N 	 1 	 lawsuit the
15 	 16 	 (S[pss]\NP)/PP 	 1 	 lawsuit launched <XB>
16 	 17 	 ((S\NP)\(S\NP))/NP 	 2 	 launched by
16 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 launched in
19 	 17 	 ((S\NP)\(S\NP))/NP 	 3 	 University by
19 	 18 	 NP[nb]/N 	 1 	 University the
19 	 20 	 (NP\NP)/NP 	 1 	 University of
21 	 20 	 (NP\NP)/NP 	 2 	 Toronto of
22 	 16 	 (S[pss]\NP)/PP 	 2 	 against launched
23 	 22 	 PP/NP 	 1 	 Connaught against
25 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 connection in
25 	 26 	 (NP\NP)/NP 	 1 	 connection with
29 	 26 	 (NP\NP)/NP 	 2 	 bid with
29 	 27 	 NP[nb]/N 	 1 	 bid the
29 	 28 	 N/N 	 1 	 bid Merieux
<\s>
<s id="wsj_0533.14"> 49
2 	 0 	 (S/S)/NP 	 2 	 statement In
2 	 1 	 NP[nb]/N 	 1 	 statement a
2 	 3 	 (S[pss]\NP)/PP 	 1 	 statement prepared <XB>
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 prepared by
5 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 lawyers by
6 	 3 	 (S[pss]\NP)/PP 	 2 	 for prepared
8 	 6 	 PP/NP 	 1 	 university for
8 	 7 	 NP[nb]/N 	 1 	 university the
10 	 6 	 PP/NP 	 1 	 Connaught for
13 	 12 	 NP[nb]/N 	 1 	 parties the
13 	 14 	 (S[dcl]\NP)/S[dcl] 	 1 	 parties said
14 	 0 	 (S/S)/NP 	 1 	 said In
15 	 16 	 (S[dcl]\NP)/S[em] 	 1 	 they agreed
16 	 14 	 (S[dcl]\NP)/S[dcl] 	 2 	 agreed said
17 	 16 	 (S[dcl]\NP)/S[em] 	 2 	 that agreed
20 	 18 	 (S/S)/NP 	 2 	 result as
20 	 19 	 NP[nb]/N 	 1 	 result a
20 	 21 	 (NP\NP)/(S[ng]\NP) 	 1 	 result of
22 	 21 	 (NP\NP)/(S[ng]\NP) 	 2 	 reaching of
26 	 24 	 (N/N)/N[num] 	 2 	 million C
26 	 25 	 N/N 	 1 	 million 415
28 	 22 	 (S[ng]\NP)/NP 	 2 	 accord reaching
28 	 23 	 NP[nb]/N 	 1 	 accord a
28 	 24 	 (N/N)/N[num] 	 1 	 accord C
28 	 27 	 N/N 	 1 	 accord research
30 	 31 	 ((S[dcl]\NP[expl])/S[em])/(S[adj]\NP) 	 1 	 It is
31 	 17 	 S[em]/S[dcl] 	 1 	 is that
31 	 18 	 (S/S)/NP 	 1 	 is as
32 	 31 	 ((S[dcl]\NP[expl])/S[em])/(S[adj]\NP) 	 3 	 unnecessary is
33 	 31 	 ((S[dcl]\NP[expl])/S[em])/(S[adj]\NP) 	 2 	 that is
34 	 35 	 (S[b]\NP[thr])/NP 	 1 	 there be
35 	 33 	 S[em]/S[b] 	 1 	 be that
35 	 46 	 ((S\NP)\(S\NP))/NP 	 2 	 be at
37 	 35 	 (S[b]\NP[thr])/NP 	 2 	 judgment be
37 	 36 	 NP[nb]/N 	 1 	 judgment a
37 	 38 	 (NP\NP)/NP 	 1 	 judgment on
40 	 38 	 (NP\NP)/NP 	 2 	 merits on
40 	 39 	 NP[nb]/N 	 1 	 merits the
40 	 42 	 (NP\NP)/NP 	 1 	 merits of
44 	 42 	 (NP\NP)/NP 	 2 	 case of
44 	 43 	 NP[nb]/N 	 1 	 case the
48 	 46 	 ((S\NP)\(S\NP))/NP 	 3 	 time at
48 	 47 	 NP[nb]/N 	 1 	 time this
<\s>
<s id="wsj_0533.15"> 11
0 	 1 	 (NP\NP)/NP 	 1 	 Lawyers for
0 	 5 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 Lawyers were
0 	 8 	 (S[adj]\NP)/PP 	 1 	 Lawyers available <XB>
4 	 1 	 (NP\NP)/NP 	 2 	 sides for
4 	 2 	 NP[nb]/N 	 1 	 sides the
4 	 3 	 N/N 	 1 	 sides two
5 	 6 	 (S\NP)\(S\NP) 	 2 	 were n't
5 	 7 	 (S\NP)\(S\NP) 	 2 	 were immediately
8 	 5 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 available were
9 	 8 	 (S[adj]\NP)/PP 	 2 	 for available
10 	 9 	 PP/NP 	 1 	 comment for
<\s>
<s id="wsj_0533.16"> 21
1 	 0 	 NP[nb]/N 	 1 	 university The
1 	 2 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 university had
1 	 3 	 (S[pt]\NP)/NP 	 1 	 university sought <XB>
3 	 2 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 sought had
5 	 3 	 (S[pt]\NP)/NP 	 2 	 injunction sought
5 	 4 	 NP[nb]/N 	 1 	 injunction an
5 	 6 	 ((S[ng]\NP)/PP)/NP 	 1 	 injunction blocking <XB>
7 	 8 	 (NP[nb]/N)\NP 	 2 	 Connaught 's
9 	 6 	 ((S[ng]\NP)/PP)/NP 	 3 	 board blocking
9 	 8 	 (NP[nb]/N)\NP 	 1 	 board 's
10 	 6 	 ((S[ng]\NP)/PP)/NP 	 2 	 from blocking
11 	 10 	 PP/NP 	 1 	 recommending from
13 	 10 	 PP/NP 	 1 	 supporting from
15 	 11 	 (S[ng]\NP)/NP 	 2 	 offer recommending <XU>
15 	 13 	 (S[ng]\NP)/NP 	 2 	 offer supporting
15 	 14 	 NP[nb]/N 	 1 	 offer an
15 	 16 	 (NP\NP)/NP 	 1 	 offer for
15 	 19 	 (NP\NP)/NP 	 1 	 offer by
18 	 16 	 (NP\NP)/NP 	 2 	 company for
18 	 17 	 NP[nb]/N 	 1 	 company the
20 	 19 	 (NP\NP)/NP 	 2 	 Merieux by
<\s>
